Although 17β-estradiol (E2) treatment of breast cancer cell lines induced cell proliferation in an mTOR dependent manner, the molecular mechanism underlying mTOR-mediated ERα signaling in breast cancer remains unclear [16, 17]. Here, MTOR is linked to breast cancer.